Interestingly, among T2DM patients, those with good glycemic control during the follow-up showed a higher amount of Ang 1–9, Ang 1–7, and MasR, and a lower amount of NAFT than patients with poor glycemic control (Fig. 6). This evidence concerns the gene MAS1L and type 2 diabetes mellitus.